Developmental changes of nitric oxide-sensitive guanylyl cyclase expression in pulmonary arteries.
Inhaled nitric oxide (NO) is known to influence the contractile state of pulmonary arteries most likely by activation of soluble guanylyl cyclase (sGC) in smooth muscle cells. However, the cellular distribution of sGC has not been determined empirically, due to a lack of specific antibodies. Here, we describe a novel antibody directed against the beta1 subunit of sGC to study the cellular distribution of sGC in lung during development. Using the novel antibody, the enzyme was demonstrated in fetal, neonatal, and adult lungs by Western blot, showing maximum expression in neonatal lung. These data were confirmed by measurements of sGC activity. In pulmonary arteries of fetal lung sGC-beta1 immunoreactivity was present in smooth muscle cells and absent in endothelial cells. With postnatal development an increase in immunoreactivity in endothelial cells and a reciprocal decrease in smooth muscle cells was apparent. The reported changes in sGC expression likely contribute to the known age-dependent differences in response to inhaled NO.
Behrends
S
S
Institute of Pharmacology, Institute of Anatomy, University of Hamburg, Martinistr. 52, Hamburg, 20246, Germany. behrends@plexus.uni-hamburg.de
Kempfert
J
J
Mietens
A
A
Koglin
M
M
Scholz
H
H
Middendorff
R
R
D000375:Aging / Q000378:metabolism*; D000595:Amino Acid Sequence; D000818:Animals; D000918:Antibody Specificity; D006162:Guanylate Cyclase / Q000276:immunology / Q000378:metabolism*; D007150:Immunohistochemistry; D008969:Molecular Sequence Data; D009569:Nitric Oxide / Q000378:metabolism*; D011651:Pulmonary Artery / Q000201:enzymology*; D051381:Rats; D017208:Rats, Wistar
D009569:Nitric Oxide; D006162:Guanylate Cyclase